IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma
Preprint in Research Square (April 2024)
The most recent citing publications are shown below. View all 206 publications that cite this research output on Dimensions.
Preprint in Research Square (April 2024)
Article in International Journal of Clinical Oncology (April 2024)
Article in International Journal of Molecular Sciences (April 2024)